Javascript must be enabled to continue!
Separation and detection of minimal length isomeric glycopeptide neoantigen epitopes centering GSTA region of MUC1 by LC-MS
View through CrossRef
AbstractMUC1 ranks No.2 on the list of targets for cancer immunotherapy. We previously reported monoclonal antibodies binding to glycopeptide neoantigen epitopes centering GSTA sequence of the highly glycosylated tandem repeat region of MUC1. Epitopes centering GSTA sequence are also predicted by NetMHC programs to bind to MHC molecules, although empirical data are lacking. Detecting isomeric MUC1 glycopeptide epitopes by mass spectrometry (MS) remains a technical challenge since antigenic epitopes are often shorter than 10 amino acids. MUC1 digests by Arg-C-specific endopeptidase clostripain could generate heterogenous icosapeptides, but isomeric 20-residue glycopetides could not be separated by liquid chromatography. In this study, we used pronase fromStreptomyces griseus, which has no amino acid sequence preference for enzymatic cleavage sites, to digest a pair of synthetic glycopeptide isomers RPAPGST(Tn)APPAHG and RPAPGS(Tn)TAPPAHG, and analyzed the digests by LC-MS using electron transfer dissociation (ETD) and higher-energy collisional dissociation (HCD) methods. The results showed that glycopeptide isomers containing 8 to 11 amino acids could be efficiently generated by pronase digestion. Such glycopeptide isomers of minimal epitope lengths were clearly distinguished by characteristic MS/MS ion patterns and elution profiles of liquid chromatography. A glycopeptide library was generated which may serve as standards for measuring neoantigen epitopes centering GSTA sequence.
Title: Separation and detection of minimal length isomeric glycopeptide neoantigen epitopes centering GSTA region of MUC1 by LC-MS
Description:
AbstractMUC1 ranks No.
2 on the list of targets for cancer immunotherapy.
We previously reported monoclonal antibodies binding to glycopeptide neoantigen epitopes centering GSTA sequence of the highly glycosylated tandem repeat region of MUC1.
Epitopes centering GSTA sequence are also predicted by NetMHC programs to bind to MHC molecules, although empirical data are lacking.
Detecting isomeric MUC1 glycopeptide epitopes by mass spectrometry (MS) remains a technical challenge since antigenic epitopes are often shorter than 10 amino acids.
MUC1 digests by Arg-C-specific endopeptidase clostripain could generate heterogenous icosapeptides, but isomeric 20-residue glycopetides could not be separated by liquid chromatography.
In this study, we used pronase fromStreptomyces griseus, which has no amino acid sequence preference for enzymatic cleavage sites, to digest a pair of synthetic glycopeptide isomers RPAPGST(Tn)APPAHG and RPAPGS(Tn)TAPPAHG, and analyzed the digests by LC-MS using electron transfer dissociation (ETD) and higher-energy collisional dissociation (HCD) methods.
The results showed that glycopeptide isomers containing 8 to 11 amino acids could be efficiently generated by pronase digestion.
Such glycopeptide isomers of minimal epitope lengths were clearly distinguished by characteristic MS/MS ion patterns and elution profiles of liquid chromatography.
A glycopeptide library was generated which may serve as standards for measuring neoantigen epitopes centering GSTA sequence.
Related Results
Abstract 1837: MUC1 confers sensitivity to STAT-3 inhibitor napabucasin in pancreatic ductal adenocarcinoma cells
Abstract 1837: MUC1 confers sensitivity to STAT-3 inhibitor napabucasin in pancreatic ductal adenocarcinoma cells
Abstract
Introduction: Pancreatic cancer is the third leading cause of cancer-related deaths in the US and 95% of pancreatic cancers are Pancreatic Ductal Adenocarci...
Systematic Screening of Autosomal Dominant Tubulointerstitial Kidney Disease–MUC1 27dupC Pathogenic Variant through Exome Sequencing
Systematic Screening of Autosomal Dominant Tubulointerstitial Kidney Disease–MUC1 27dupC Pathogenic Variant through Exome Sequencing
Key Points
MUC1 is associated with autosomal dominant tubulointerstitial kidney disease, a ...
An antibody drug conjugate targeting a GSTA glycosite-signature epitope of mucin1 expressed by non-small cell lung cancer
An antibody drug conjugate targeting a GSTA glycosite-signature epitope of mucin1 expressed by non-small cell lung cancer
AbstractBackgroundAntibodies targeting abnormally glycosylated proteins have been ineffective in treating cancer. Antibody-drug conjugates are emerging as an efficient option, whic...
MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells
MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells
Abstract
The oncogenic MUC1-C protein promotes dedifferentiation of castrate-resistant prostate cancer (CRPC) and triple-negati...
Data from MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells
Data from MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells
<div>Abstract<p>The oncogenic MUC1-C protein promotes dedifferentiation of castrate-resistant prostate cancer (CRPC) and triple-negative breast cancer (TNBC) cells. Chr...
Data from MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells
Data from MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells
<div>Abstract<p>The oncogenic MUC1-C protein promotes dedifferentiation of castrate-resistant prostate cancer (CRPC) and triple-negative breast cancer (TNBC) cells. Chr...
Overexpression of Mucin 1 Suppresses the Therapeutical Efficacy of Disulfiram against Canine Mammary Tumor
Overexpression of Mucin 1 Suppresses the Therapeutical Efficacy of Disulfiram against Canine Mammary Tumor
Mucin 1 (MUC1), a transmembrane protein, is closely associated with the malignancy and metastasis of canine mammary tumors; however, the role of overexpressed MUC1 in the developme...
Abstract 1838: MUC1 serves as metabolic regulator in triple negative breast cancer
Abstract 1838: MUC1 serves as metabolic regulator in triple negative breast cancer
Abstract
Breast cancer, the second leading cause of cancer deaths in women, is the most common cancer among North American women, accounting for nearly 1 in 3 cancer...

